International Health
Volume 8 Issue 1 January 2016
http://inthealth.oxfordjournals.org/content/current

.
EDITORIAL
Violence against children and education
Karen Devries
Int. Health (2016) 8 (1): 1-2 doi:10.1093/inthealth/ihv076
Extract
In most countries around the world, children and adolescents spend more time in school than any other single location besides the family home. Whether or not children and adolescents are able to attend school, whether they are safe in school and whether they leave school with necessary learning and skills, are affected by their experiences of violence—at home, at school and in the community.
Before children get to school, they are often exposed to violence at home. Analysis of the Multiple Indicator Cluster Surveys data from 28 countries shows that 43% of children aged 2–14 years in African countries, and 9% in ‘transitional’ states, have experienced severe physical violence from caregivers.1 There are a host of negative health and social consequences associated with exposure to physical violence in childhood, especially during this early period. These include increased risk of depressive disorders and suicide attempts,2 poor educational attainment3 and increased risk of perpetrating or experiencing intimate partner …

.

Innovative financing for late-stage global health research and development: the Global Health Investment Fund
Joseph Robert Fitchetta,*, Julia Fan Lib and Rifat Atuna
Author Affiliations
aHarvard School of Public Health, Boston, MA, UK
bSeven Bridges Genomics, London, UK
Abstract
Innovative financing strategies for global health are urgently needed to reinvigorate investment and new tools for impact. Bottleneck areas along the research and development (R&D) pipeline require particular attention, such as the transitions from preclinical discovery to clinical study, and product development to implementation and delivery. Successful organizations mobilizing and disbursing resources through innovating financing mechanisms include UNITAID, the Global Fund, and Gavi, the Vaccine Alliance. Although precise numbers are poorly documented, estimated investment in low-income settings falls seriously short of local need. This commentary discusses the newly established Global Health Investment Fund as a case study to support late-stage global health R&D.